The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studies.
Open accessAbstract
BACKGROUND: Autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) are childhood onset neurodevelopmental disorders that may persist into adulthood. ASD and ADHD tend to run in families and may have a significant negative impact on the health and longevity of those with the disorder and their relatives. The aim of this study will be to analyze the risk of mortality among children, adolescents, and adults with ASD or ADHD and their first-degree relatives. METHODS/DESIGN: We will conduct a systematic review and meta-analysis of observational studies. Searches of PubMed/MEDLINE, EMBASE, PsycINFO, SCOPUS, and ISI Web of Science will be used to identify epidemiological studies. Eligible studies will be observational studies reporting study-specific data for all-cause mortality or cause-specific mortality in children, adolescents, or adults with ASD or ADHD and/or their first-degree relatives. Cohort studies and case-control studies will be included. The primary outcome will be all-cause mortality. The secondary outcome will be cause-specific mortality. Two reviewers will independently screen references identified by the literature search, as well as potentially relevant full-text articles. Data will be abstracted, and study risk of bias/methodological quality will be appraised by two reviewers independently. The methodological quality of epidemiological studies will be appraised using the Newcastle-Ottawa Scale (NOS). Conflicts at all levels of screening and abstraction will be resolved through discussion. Random-effects meta-analyses of primary studies will be conducted where appropriate. Subgroup analyses for exploring statistical heterogeneity, if feasible, will include gender, age group, ethnicity, comorbidities, classification of cause of death, and relevant study characteristics. DISCUSSION: Our study will establish the extent of the epidemiological evidence underlying the risk of mortality among children, adolescents, and adults with ASD or ADHD and their first-degree relatives. We anticipate that our findings will be of interest to patients, their families, caregivers, healthcare professionals, scientists, and policy makers. Implications for future epidemiological research will be discussed. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017059955 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“Methods The proposed systematic review will be conducted and reported in accordance with the reporting guidance provided in the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement [22] and the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) reporting guideline [23].”
MethodMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“We will evaluate statistical heterogeneity by estimating the variance between studies using the Cochran’s Q test [28] and I(2) statistic [29].”
MethodBias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · cited 2×
“Small study effects will be investigated by visual inspection of funnel plots (where appropriate) and formally tested using Egger’s [31] and Begg’s test [32], with the results considered to indicate potential small study effects when P 0.10.”
MethodInfluentialPreferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“size and its 95% confidence interval using the inverse variance method based on the DerSimonian and Laird random-effects model [27].”
MethodPRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · cited 1×
“This systematic review protocol is registered with the International Prospective Register of Systematic Reviews (PROSPERO) database (registration number: CRD42017059955) and has been reported in accordance with the PRISMA for Protocols (PRISMA-P) statement [24, 25] (see Additional file 1 for the checklist).”
MethodDermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Cited by
Catalá-López, F., Hutton, B., Page, M. J., Driver, J. A., Ridao, M., Alonso-Arroyo, A., Valencia, A., Macías Saint-Gerons, D., & Tabarés-Seisdedos, R. (2022) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2021.6401 · Cited by 148
Self-citationDopamine beta‐hydroxylase and its genetic variants in human health and disease
Gonzalez‐Lopez, E., & Vrana, K. E. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14893 · Cited by 100
“Patients carrying either the heterozygous or homozygous rs2519154 polymorphism had a better response to atomoxetine, a mainline medication for ADHD treatment, compared to wild-type (Fang et al. 2015).”
ResultInfluentialGut-brain axis: A matter of concern in neuropsychiatric disorders…!
Naveed, M., Zhou, Q.-G., Chu, X., Taleb, A., Meng, F. J., Ahmed, B., Zhang, Y., Fukunaga, K., & Han, F. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110051 · Cited by 100
Prevalence of dementia in ischaemic or mixed stroke populations: systematic review and meta-analysis
Craig, L., Hoo, Z. L., Yan, T. Z., Wardlaw, J. M., & Quinn, T. J. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325796 · Cited by 75
Forés-Martos, J., Catalá-López, F., Sánchez-Valle, J., Ibáñez, K., Tejero, H., Palma‐Gudiel, H., Climent, J., Pancaldi, V., Fañanás, L., Arango, C., et al. (2019) · Molecular Autism · doi:10.1186/s13229-019-0262-8 · Cited by 59
Self-citation
Metadata
- Authors
- Catalá-López, F., Hutton, B., Page, M. J., Ridao, M., Driver, J. A., Alonso-Arroyo, A., Forés-Martos, J., Macías Saint-Gerons, D., Vieta, E., Valencia, A., & Tabarés-Seisdedos, R.
- Affiliations
- Universitat de València (ES)
- University of Ottawa (CA)
- Monash University (AU)
- Brigham and Women's Hospital (US)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Barcelona Supercomputing Center (ES)
- Corresponding author
- Catalá-López, Ferrán
- ORCID
- Venue
- Systematic Reviews
- Published
- 2017-09-15
- Volume
- 6
- Issue
- 1
- Pages
- 189-189
- ISSN
- 2046-4053 (ISSN-L)
- PMC
- PMC5603059
- OpenAlex
- W2755380923
- Cited by
- 11
- References
- 49
- Citations by year
- 2025: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 1
- FWCI
- 0.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Systematic Reviews (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, other-oa)
- uO Research (University of Ottawa) (submittedVersion, public-domain)
- Funders
- Generalitat Valenciana ((PROMETEOII/2015/021))
- Centro de Investigación Biomédica en Red de Salud Mental (NA)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Keywords
- autism spectrum disorder, attention deficit hyperactivity disorder, mortality risk, first-degree relatives, family history (medicine), neurodevelopmental disorders, cause-specific mortality, all-cause mortality, children and adolescents, adults
- MeSH terms
- Autism Spectrum Disorder, Systematic Reviews as Topic, Adolescent, Adult, Attention Deficit Disorder with Hyperactivity, Cause of Death, Child, Family, Female, Humans, Male, Research Design, Risk, Meta-Analysis as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studies. https://app.cochat.ai/papers/10.1186/s13643-017-0581-9
- The paper
- Catalá-López, F., Hutton, B., Page, M. J., Ridao, M., Driver, J. A., Alonso-Arroyo, A., Forés-Martos, J., Macías Saint-Gerons, D., Vieta, E., Valencia, A., & Tabarés-Seisdedos, R. (2017). Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studies. Systematic Reviews. https://doi.org/10.1186/s13643-017-0581-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.